A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients (Q39753928)

14 September 2017

A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients (English)

1 reference

14 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Jin-You Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Chao-Fu Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Shi-Lin Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Bo Dai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ding-Wei Ye

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

14 February 2014

1 reference

Chinese Journal of Cancer

14 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

241-248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

cites work

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Management of prostate cancer in China: a multicenter report of 6 institutions

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Factors predicting prostatic biopsy Gleason sum under grading.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026544

Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer

20 August 2018

1 reference

12 December 2020

Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation

1 reference

12 December 2020

The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy

1 reference

12 December 2020

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series

1 reference

12 December 2020

Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables

1 reference

12 December 2020

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

12 December 2020

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

1 reference

12 December 2020

Identifiers

DOI

10.5732/CJC.013.10137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559852%20AND%20SRC:MED&resulttype=core&format=json